GlassScript

Boston Scientific Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$385Mgeneral payments (2019-2025)
$945Kresearch payments (2019-2025)
198,635clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $82M
2020 $29M
2021 $37M
2022 $56M
2023 $41M
2024 $49M
2025 $90M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Clinical Cardiac Electrophysiology $62M
Urology $57M
Thoracic Surgery (Cardiothoracic Vascular Surgery) $43M
Vascular & Interventional Radiology $35M
Interventional Cardiology $29M
Cardiovascular Disease $25M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Steven Bolling Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $41,356,031.10
Matthew Allaway Cumberland, MD Urology $20,623,970.32
Gust Bardy Seattle, WA Clinical Cardiac Electrophysiology $20,169,859.42
Rahmi Oklu Scottsdale, AZ Vascular & Interventional Radiology $16,857,834.29
David Dove East Hampton, NY Internal Medicine $12,257,628.69
Ashok Reddy Sterling Heights, MI Urology $4,879,428.39
Vivek Reddy New York, NY Clinical Cardiac Electrophysiology $3,643,898.91
Jason Rogers Sacramento, CA Cardiovascular Disease $3,146,749.49
Srinivas Dukkipati New York, NY Clinical Cardiac Electrophysiology $2,689,788.27
Steven Mickelsen Iowa City, IA Clinical Cardiac Electrophysiology $2,179,733.46

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.